Showing 5241-5250 of 10573 results for "".
- Measure Up Data Support Long-Term Laboratory Safety With Upadacitinib in Atopic Dermatitishttps://practicaldermatology.com/news/measure-up-data-support-long-term-laboratory-safety-with-upadacitinib-in-atopic-dermatitis/2487114/Most laboratory parameters remained within normal limits through 140 weeks of upadacitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to findings presented at the 2026 Society for Investigative Dermatology Annual
- Global Skin Cancer Burden Projected to Rise Through 2050: Studyhttps://practicaldermatology.com/news/global-skin-cancer-burden-projected-to-rise-through-2050/2487086/A new research letter published online in JAMA Dermatology highlights widening global disparities in skin cancer burden and projects continued increases in melanoma, cutaneous squamous cell carcinoma (cSCC), and basal cell c
- Short-Term Corticosteroid Use Not Linked to Increased IOP in 3 Trialshttps://practicaldermatology.com/news/short-term-corticosteroid-use-not-linked-to-increased-iop-in-3-trials/2487073/A pooled analysis of 3 randomized clinical trials found no evidence that short-term topical or systemic corticosteroid therapy increases intraocular pressure (IOP), a concern associated with corticosteroid-induced glaucoma. T
- Iron Oxides in Tinted Sunscreens May Improve Hyperpigmentation Protection: Studyhttps://practicaldermatology.com/news/iron-oxides-in-tinted-sunscreens-may-improve-hyperpigmentation-protection-study/2487035/A literature review and product analysis published in the Journal of Drugs in Dermatology highlighted growing evidence supporting the use of iron oxides in tinted sunscreens for managing hyperpigmentation, while also identif
- Long-Term Dupilumab Use Linked to Delayed Relapse in AD: Studyhttps://practicaldermatology.com/news/long-term-dupilumab-use-linked-to-delayed-relapse-in-ad-study/2487027/Patients with moderate-to-severe atopic dermatitis (AD) treated with dupilumab experienced durable symptom control and delayed relapse with long-term therapy, according to a real-world retrospective study published in the Journal
- Analysis: Black Children Show Lower Dermatology Specialty Care Use Despite Higher Disease Frequencyhttps://practicaldermatology.com/news/black-children-show-lower-dermatology-use-despite-higher-disease-frequency/2486986/Black children had higher electronic health record (EHR)–derived frequencies of atopic dermatitis (AD), acne, and hidradenitis suppurativa compared with White children across 8 US children’s hospitals. Investigators for the multicenter cross-sectional study
- Aging Cohort Analysis IDs Predictors of Stronger Epidermal Barrier Functionhttps://practicaldermatology.com/news/aging-cohort-analysis-ids-predictors-of-stronger-epidermal-barrier-function/2486981/A large population-based analysis from the Baltimore Longitudinal Study of Aging identified several demographic factors associated with stronger skin barrier function, according to findings presented by Katrina Abuabara, MD, MSCE, and colleagues.
- Reduced AMP Expression Seen in Sensitive Skin Syndrome: Pilot Studyhttps://practicaldermatology.com/news/reduced-amp-expression-seen-in-sensitive-skin-syndrome-pilot-study/2486974/A pilot study published in the Journal of the American Academy of Dermatology evaluated whether key pathophysiologic features of rosacea—Demodex colonization and antimicrobial peptide (AMP) dysregulation—are also present in
- Rapid Weight Loss Brings Expanding Soft Tissue Concerns to Dermatologyhttps://practicaldermatology.com/news/rapid-weight-loss-brings-expanding-soft-tissue-concerns-to-dermatology/2486936/A new analysis suggests rapid weight loss from GLP-1 agents, bariatric surgery, or lifestyle change is associated with measurable declines in skin elasticity and soft tissue volume.Rapid and intentional weight loss (driven by bariatric surgery, glucagon-l
- Exosomes in Dermatology: Emerging Adjuncts With Uncertain Standardizationhttps://practicaldermatology.com/news/exosomes-in-dermatology-emerging-adjuncts-with-uncertain-standardization/2486899/A recent narrative synthesized evidence from 2020 to 2025 on exosome-based therapeutics, highlighting their expanding role in dermatology and regenerative medicine. Across dermatologic applications, the authors wrote, precli